The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay

Journal of Pediatric Hematology/Oncology

Volumn 37, Issue 1, 2015, Pages 10-15

  Brandow, Amanda M ^a,c,d   Farley, Rebecca A ^a,c   Dasgupta, Mahua ^b,c   Hoffmann, Raymond G ^b,c,d   Panepinto, Julie A ^a,c,d  

^a Section of Pediatric Hematology/Oncology   (United States)

^b Critical Care Section   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d Children's Hospital of Wisconsin   (United States)

Author keywords

length of stay; neuropathic pain; neuropathic pain drugs; sickle cell disease

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; FLUOXETINE; GABAPENTIN; NORTRIPTYLINE; PAROXETINE; PHENYTOIN; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOSPITALIZATION; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; RETROSPECTIVE STUDY; SENESCENCE; SEX DIFFERENCE; SICKLE CELL ANEMIA; AGE; NEURALGIA; NEWBORN; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; AGE FACTORS; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LENGTH OF STAY; MALE; NEURALGIA; SEX FACTORS;

EID: 84920604026     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000265     Document Type: Article

References (34)

1. Freynhagen R, Bennett MI. Diagnosis and management of neuropathic pain. BMJ. 2009;339:b3002.
2. Treede RD, Meyer RA, Raja SN, et al. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol. 1992; 38:397-421.
3. Sethna NF, Meier PM, Zurakowski D, et al. Cutaneous sensory abnormalities in children and adolescents with complex regional pain syndromes. Pain. 2007;131:153-161.
4. Nolan VG, Zhang Y, Lash T, et al. Association between wind speed and the occurrence of sickle cell acute painful episodes: results of a case-crossover study. Br J Haematol. 2008;143: 433-438.
5. Smith WR, Bauserman RL, Ballas SK, et al. Climatic and geographic temporal patterns of pain in the Multicenter Study of Hydroxyurea. Pain. 2009;146:91-98.
6. Resar LM, Oski FA. Cold water exposure and vaso-occlusive crises in sickle cell anemia. J Pediatr. 1991;118:407-409.
7. Walco GA, Dampier CD. Pain in children and adolescents with sickle cell disease: a descriptive study. J Pediatr Psychol. 1990;15:643-658.
8. Wang WC. Pain at home in sickle cell disease: an under-recognized problem. J Pediatr Hematol Oncol. 2002;24: 610-612.
9. Wilkie DJ, Molokie R, Boyd-Seal D, et al. Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease. J Natl Med Assoc. 2010;102:18-27.
10. Brandow AM, Farley R, Panepinto JA. Neuropathic pain in patients with sickle cell disease. Pediatr Blood Cancer. 2014;61:512-517.
11. Hillery CA, Kerstein PC, Vilceanu D, et al. Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease. Blood. 2011;118:3376-3383.
12. Kohli DR, Li Y, Khasabov SG, et al. Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. Blood. 2010;116: 456-465.
13. Brandow AM, Stucky CL, Hillery CA, et al. Patients with sickle cell disease have increased sensitivity to cold and heat. Am J Hematol. 2013;88:37-43.
14. Edwards RR, Fillingim RB. Effects of age on temporal summation and habituation of thermal pain: clinical relevance in healthy older and younger adults. J Pain. 2001;2: 307-317.
15. Edwards RR, Fillingim RB. Age-associated differences in responses to noxious stimuli. J Gerontol A Biol Sci Med Sci. 2001;56:M180-M185.
16. Edwards RR, Fillingim RB, Ness TJ. Age-related differences in endogenous pain modulation: a comparison of diffuse noxious inhibitory controls in healthy older and younger adults. Pain. 2003;101:155-165.
17. Torrance N, Smith BH, Bennett MI, et al. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain. 2006;7: 281-289.
18. Butler S, Jonzon B, Branting-Ekenback C, et al. Predictors of severe pain in a cohort of 5271 individuals with self-reported neuropathic pain. Pain. 2013;154:141-146.
19. Boogaard S, De Vet HC, Faber CG, et al. An overview of predictors for persistent neuropathic pain. Expert Rev Neuro-therapeut. 2013;13:505-513.
20. Bouhassira D, Lanteri-Minet M, Attal N, et al. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136:380-387.
21. Smith WR, Penberthy LT, Bovbjerg VE, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med. 2008;148:94-101.
22. Panepinto JA, Brousseau DC, Hillery CA, et al. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer. 2005;44:182-186.
23. Magrinelli F, Zanette G, Tamburin S. Neuropathic pain: diagnosis and treatment. Pract Neurol. 2013;13:292-307.
24. Vadalouca A, Raptis E, Moka E, et al. Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature. Pain Pract. 2012;12:219-251.
25. Piano V, Verhagen S, Schalkwijk A, et al. Treatment for neuropathic pain in patients with cancer: comparative analysis of recommendations in National Clinical Practice Guidelines from European Countries. Pain Pract. 2014;14:1-7.
26. Shankar SM, Arbogast PG, Mitchel E, et al. Medical care utilization and mortality in sickle cell disease: a population-based study. Am J Hematol. 2005;80:262-270.
27. Amendah DD, Mvundura M, Kavanagh PL, et al. Sickle cell disease-related pediatric medical expenditures in the U.S. Am J Prev Med. 2010;38:S550-S556.
28. O'Leary JD, Crawford MW, Odame I, et al. Thermal pain and sensory processing in children with sickle cell disease. Clin J Pain. 2014;30:244-250.
29. Lempp HK, Hatch SL, Carville SF, et al. Patients' experiences of living with and receiving treatment for fibromyalgia syndrome: a qualitative study. BMC Musculoskelet Disord. 2009;10:124.
30. Unruh AM. Gender variations in clinical pain experience. Pain. 1996;65:123-167.
31. Riley JL III, Robinson ME, Wise EA, et al. Sex differences in the perception of noxious experimental stimuli: a meta-analysis. Pain. 1998;74:181-187.
32. Paller CJ, Campbell CM, Edwards RR, et al. Sex-based differences in pain perception and treatment. Pain Med. 2009;10:289-299.
33. Fillingim RB, King CD, Ribeiro-Dasilva MC, et al. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain. 2009;10:447-485.
34. Brandow AM, Weisman SJ, Panepinto JA. The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations. Pediatr Blood Cancer. 2011;56:789-793.